Daniel J Lindner

6PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 12, 2023
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma.

Neetha Parameswaran, Liping Luo, Lingjun Zhang

|Jun 28, 2023
Unrestricted Ketogenic Diet Feeding Enhances Epithelial Ovarian Cancer Growth In Vivo.

Mariam M AlHilli, Emily E Rhoades, Danielle Chau

|Jan 13, 2023
KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.

Hong Qiu, Vladimir Makarov, Jennifer K Bolzenius

|Jun 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.

Sunisa Kongkiatkamon, Laila Terkawi, Yihong Guan

|Jun 02, 2021
Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma.

Metis Hasipek, Dale Grabowski, Yihong Guan

|Mar 08, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.

Yihong Guan, Anand D Tiwari, James G Phillips

Pageof 1

Frequent Collaborators

3 joint publications

Yihong Guan

3 joint publications

Babal K Jha

2 joint publications

Yvonne Parker

1 joint publications

Anand D Tiwari